Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 11.30
-0.22 (-1.91%)
At close: Dec 30, 2025
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of 3.18 billion as of December 31, 2025. Its market cap has increased by 77.27% in one year.
Market Cap
3.18B
Enterprise Value
2.35B
Revenue
8.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.30
Market Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from 87.82M to 3.18B, an increase of 3,522.60%. That is a compound annual growth rate of 42.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.18B | 60.49% |
| Dec 30, 2024 | 1.98B | 25.12% |
| Dec 29, 2023 | 1.58B | 8.13% |
| Dec 30, 2022 | 1.47B | 46.67% |
| Dec 30, 2021 | 998.90M | -47.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.91B |
| Getinge AB | 59.27B |
| Sectra AB | 48.17B |
| Camurus AB | 37.07B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.59B |
| BioArctic AB | 27.78B |
| Elekta AB | 21.80B |